← The Wire
CPRXNasdaq
CATALYST PHARMACEUTICALS, INC.
Pharmaceutical Preparations · DE · CIK 1369568
Catalyst Pharmaceuticals, Inc. develops and commercializes treatments for rare neurological diseases
$3.84B
Market cap
$31.46
Last close
-0.1%
1D
+0.3%
5D
1.8M
Volume
Price · last 39 sessions+8.7%
May 4L $28.94 · H $31.50Jun 29
343
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
8-KCompany UpdateJun 23, 2026DEFA14ADEFA14AMay 12, 20268-KCompany UpdateMay 11, 202610-Q10-QMay 11, 2026DEFA14ADEFA14AMay 8, 2026DEFA14ADEFA14AMay 7, 2026DEFA14ADEFA14AMay 7, 20268-KMaterial Agreement · Bylaw AmendmentMay 7, 202610-K/A10-K/AApr 30, 20268-K/ACompany UpdateMar 19, 20268-KCompany UpdateMar 18, 20268-KCompany UpdateFeb 25, 202610-K10-KFeb 25, 20268-KReg FD DisclosureJan 12, 20268-KCompany UpdateNov 5, 202510-Q10-QNov 5, 20258-KCompany UpdateOct 1, 20258-K/ACompany UpdateAug 28, 20258-KCompany UpdateAug 25, 20258-KCompany UpdateAug 7, 20258-KCompany UpdateAug 6, 202510-Q10-QAug 6, 20258-KExecutive ChangeAug 4, 20258-KCompany UpdateJun 2, 20258-KExecutive Change · Shareholder VoteMay 23, 20258-KCompany UpdateMay 7, 202510-Q10-QMay 7, 2025DEF 14ADEF 14AApr 11, 20258-KCompany UpdateApr 9, 20258-KCompany UpdateFeb 26, 202510-K10-KFeb 26, 20258-KExecutive ChangeJan 24, 20258-KCompany UpdateJan 21, 20258-KReg FD DisclosureJan 13, 20258-KCompany UpdateJan 8, 20258-KCompany UpdateNov 6, 202410-Q10-QNov 6, 20248-KCompany UpdateSep 26, 20248-KCompany UpdateAug 7, 202410-Q10-QAug 7, 20248-KCompany UpdateJul 26, 20248-KCompany UpdateMay 30, 20248-KExecutive Change · Shareholder VoteMay 21, 20248-KCompany UpdateMay 8, 202410-QFORM 10-QMay 8, 2024DEF 14ADEF 14AApr 10, 20248-KCompany UpdateMar 13, 20248-KCompany UpdateFeb 29, 202410-KFORM 10-KFeb 28, 20248-KCompany UpdateFeb 21, 20248-KCompany UpdateJan 9, 20248-KReg FD DisclosureJan 8, 20248-KMaterial Agreement · Reg FD DisclosureJan 5, 2024424B5FORM 424(B)(5)Jan 5, 2024424B5FORM 424(B)(5)Jan 5, 20248-KCompany UpdateDec 19, 20238-KExecutive ChangeDec 7, 20238-KCompany UpdateNov 8, 202310-QFORM 10-QNov 8, 20238-KCompany UpdateNov 3, 20238-KCompany UpdateOct 27, 20238-KExecutive ChangeOct 20, 20238-KCompany UpdateOct 13, 20238-KReg FD DisclosureSep 26, 20238-KExecutive Change · Shareholder VoteAug 25, 20238-KCompany UpdateAug 9, 202310-QFORM 10-QAug 9, 20238-KExecutive ChangeJul 28, 20238-KAcquisition / Disposition · Company UpdateJul 21, 2023DEF 14ADEF 14AJul 12, 20238-KMaterial Agreement · Company UpdateJun 23, 20238-KCompany UpdateJun 1, 20238-KExecutive ChangeMay 30, 20238-KCompany UpdateMay 10, 202310-QFORM 10-QMay 10, 20238-KCompany UpdateMay 9, 202310-K/AFORM 10-K/AApr 24, 20238-K/ACompany UpdateApr 10, 20238-KExecutive ChangeMar 31, 20238-KCompany UpdateMar 15, 2023
Insider Activity
In the 90 days to Dec 12, 2025: 3 sold $1.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 2025 | Harper MollyDirector | Sell | 15,527 | $23.20 | $360K |
| Dec 12, 2025 | Harper MollyDirector | Sell | 6,746 | $23.06 | $156K |
| Dec 12, 2025 | Harper MollyDirector | Sell | 4,473 | $23.73 | $106K |
| Nov 26, 2025 | Del Carmen JeffreyChief Commercial Officer | Sell | 10,983 | $23.33 | $256K |
| Nov 12, 2025 | Elsbernd BrianChief Compliance/Legal Officer | Sell | 40,000 | $22.70 | $908K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance